Imexpharm Corp Financial Flexibility Index
Imexpharm Corp financial flexibility index. Imexpharm Corp (IMP) has a Financial Flexibility Index of 0.12x as of June 2026. Free cash flow of ₫72.65 Billion (operating CF ₫55.75 Billion minus capex ₫16.90 Billion) represents 0% of total liabilities (₫605.60 Billion). Explore Imexpharm Corp capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Imexpharm Corp (2019–2025)
Financial flexibility index of Imexpharm Corp from 2019 to 2025. Historical Financial Flexibility Index trend for Imexpharm Corp across 7 annual periods. Check cash flow reinvestment rate of Imexpharm Corp to assess the company's total reinvestment commitment from operating cash flow.
Imexpharm Corp Financial Flexibility Index by Year (2019–2025)
Imexpharm Corp financial flexibility index by year from 2019 to 2025. Year-by-year free cash flow to debt coverage for Imexpharm Corp. For the full cash flow conversion analysis, see IMP operating cash flow.
| Year | Flexibility Index | Free Cash Flow (VND) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | ₫81.05 Billion | ₫54.17 Billion | ₫476.11 Billion | ▼ -82.5% |
| 2024 | 0.97x | ₫313.04 Billion | ₫216.27 Billion | ₫321.66 Billion | ▲ +1225.1% |
| 2023 | 0.07x | ₫22.62 Billion | ₫-40.47 Billion | ₫308.04 Billion | ▼ -94.1% |
| 2022 | 1.25x | ₫477.96 Billion | ₫378.60 Billion | ₫382.50 Billion | ▲ +117.3% |
| 2021 | 0.58x | ₫287.74 Billion | ₫234.88 Billion | ₫500.29 Billion | ▲ +29.3% |
| 2020 | 0.44x | ₫162.84 Billion | ₫73.15 Billion | ₫365.97 Billion | ▼ -35.1% |
| 2019 | 0.69x | ₫197.72 Billion | ₫66.59 Billion | ₫288.29 Billion | — |